Glenn Cohen, Nicholson Price, and Katharina Ó Cathaoiron on Bias in Medical AI

Virtual option via Zoom (link will be provided at registration)

Metro stop “Islands Brygge”

Parking at the University of Copenhagen parking lot 

I. Glenn Cohen

I. Glenn Cohen, JD, PhD, is a Deputy Dean and James A. Attwood and Leslie Williams Professor of Law, Harvard Law School as well as the Faculty Director of the Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics. His work focuses on how the law grapples with new medical technologies – including reproductive technologies, psychedelics, and artificial intelligence. He is co-PI of the Project on Precision Medicine, Artificial Intelligence, and the Law at the Petrie-Flom Center at Harvard Law School and a Core Partner at the University of Copenhagen’s Center for Advanced Studies in Biomedical Innovation Law (CeBIL).

Nicholson Price

Nicholson Price, JD, PhD, is a Professor of Law at the University of Michigan Law School. His work considers how various areas of law shape biomedical innovation, including the use of big data and artificial intelligence, drug manufacturing, and drug development.  Heis co-PI of the Project on Precision Medicine, Artificial Intelligence, and the Law at the Petrie-Flom Center at Harvard Law School and a Core Partner at the University of Copenhagen’s Center for Advanced Studies in Biomedical Innovation Law (CeBIL).

Katharina Ó Cathaoir

Katharina Ó Cathaoir, PhD, is an Associate Professor of Law at the Faculty of Law, University of Copenhagen and Pro Futura Scientia Fellow at the Swedish Collegium for Advanced Study. Katharina’s work explores the rights of those at the margins of health law, including older people, children and migrants. She is particularly interested in the implications of data driven treatment for such groups, namely questions of access and acceptability.

Timo Minssen

Timo Minssen is Professor of Law at the University of Copenhagen and the Founder and Managing Director of the Center for Advanced Studies in Biomedical Innovation Law (CeBIL). As a leading European authority with close to 200 publications in the area, Timo is also an LML Research Affiliate with the University of Cambridge. His research and advisory practice concentrates on Intellectual Property-, Competition, Data Protection & Regulatory Law with a special focus on new technologies in the health & life sciences including artificial intelligence and quantum technology. His studies comprise a plethora of legal and ethical issues emerging in the lifecycle of relevant products and processes - from the regulation of responsible research and incentives for innovation to sustainable drug development, technology transfer and commercialization.